This review examines the goals of antihyperglycemic therapy and the mechanisms of action, efficacy, nonglycemic benefits,
cost, and safety profile of each of the five approved classes of oral agents. A rationale for the use of these agents as monotherapy,
in combination with each other, and in combination with insulin is also provided.